Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV infected individuals

被引:115
作者
Anderson, PL [1 ]
Kakuda, TN [1 ]
Kawle, S [1 ]
Fletcher, CV [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Antiviral Pharmacol Lab, Denver, CO 80262 USA
关键词
adherence; antiretroviral therapy; clinical pharmacology; HIV; nucleoside analog reverse transcriptase inhibitor; pharmacodynamics; pharmacokinetics; phosphorylation; triphosphate; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITOR THERAPY; NUCLEOSIDE-ANALOG THERAPY; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; PHOSPHORYLATION; PHARMACOLOGY; AIDS; PHARMACOKINETICS;
D O I
10.1097/00002030-200310170-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Nucleoside analog reverse transcriptase inhibitors (NRTI) are used in virtually all anti-HIV regimens. Clinical response depends on the intracellular formation of the pharmacologically active triphosphate moiety. Our objective was to quantify the pharmacological characteristics of zidovudine and lamivudine triphosphate in HIV-infected individuals. Methods: Peripheral blood mononuclear cells were obtained at multiple planned intervals from anti retroviral-naive adults participating in a study of zidovudine, lamivudine and indinavir, and triphosphate levels were determined by immunoassay and high-performance liquid chromatography/mass spectrometry. Plasma HIV-RNA, CD4 cell counts, and plasma drug concentrations were collected over 18 months. Data were analysed using non-parametric, regression and time-to-event methods. Results: Thirty-three subjects were evaluated. The estimated half-lives of zidovudine and lamivudine triphosphate were 7 and 22 h, respectively. Triphosphate concentrations were elevated in individuals with low baseline CD4 cell counts. Triphosphate concentrations in women were higher than in men by 2.3 and 1.6-fold for zidovudine and lamivudine, respectively. Women reached an HIV-RNA level under 50 copies/ml twice as fast as men. Zidovudine triphosphate above 30 fmol/10(6) cells was independently predictive of the time to under 50 copies/ml. Lamivudine triphosphate above 7017 fmol/106 cells was independently predictive of a longer virological response. Indinavir concentrations were related to antiviral responses in univariate analyses. Conclusion: Zidovudine and lamivudine triphosphate concentration thresholds were independently associated with the antiviral activity of zidovudine, lamivudine, and indinavir. The significantly elevated triphosphate concentrations in women and individuals with low baseline CD4 cell counts, groups that historically experience high rates of serious NRTI toxicities, provide a hypothesis for the pathogenesis of these events. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:2159 / 2168
页数:10
相关论文
共 37 条
  • [1] [Anonymous], 39 INT C ANT AG CHEM
  • [2] ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED PATIENTS AND SERONEGATIVE VOLUNTEERS
    BARRY, M
    WILD, M
    VEAL, G
    BACK, D
    BRECKENRIDGE, A
    FOX, R
    BEECHING, N
    NYE, F
    CAREY, P
    TIMMINS, D
    [J]. AIDS, 1994, 8 (08) : F1 - F5
  • [3] Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy
    Behbahani, H
    Landay, A
    Patterson, BK
    Jones, P
    Pottage, J
    Agnoli, M
    Andersson, J
    Spetz, AL
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) : 150 - 156
  • [4] Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: A novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
    Cannavo, G
    Paiardini, M
    Galati, D
    Cervasi, B
    Montroni, M
    De Vico, G
    Guetard, D
    Bocchino, ML
    Picerno, I
    Magnani, M
    Silvestri, G
    Piedimonte, G
    [J]. BLOOD, 2001, 97 (06) : 1756 - 1764
  • [5] Adverse effects of antiretroviral therapy
    Carr, A
    Cooper, DA
    [J]. LANCET, 2000, 356 (9239) : 1423 - 1430
  • [6] Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients
    Chêne, G
    Angelini, E
    Cotte, L
    Lang, JM
    Morlat, P
    Rancinan, C
    May, T
    Journot, V
    Raffi, F
    Jarrousse, B
    Grappin, M
    Lepeu, G
    Molina, JM
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) : 649 - 657
  • [7] A systematic review of the associations between dose regimens and medication compliance
    Claxton, AJ
    Cramer, J
    Pierce, C
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (08) : 1296 - 1310
  • [8] CURRIER J, 2002, AIDS READER, V12, P124
  • [9] Currier JS, 2000, J ACQ IMMUN DEF SYND, V24, P316
  • [10] Currier Judith, 2002, AIDS Read, V12, P114